Semintra (Telmisartan) Oral Solution dilates the blood vessels, improving blood flow and controlling hypertension. Taking regular hypertension medication can help protect your cat from complications caused by this disease, such as damage to the kidneys, eyes, brain and heart. For your convenience, Semintra comes with a syringe for easy-to-use liquid dosing. FDA approved.How it Works

The active ingredient in SEMINTRA® (telmisartan oral solution), telmisartan, belongs to a class of drugs called angiotensin receptor blockers (ARBs).1 Telmisartan helps to lower blood pressure by selectively blocking the peptide hormone the body uses to constrict blood vessels.7 This allows the blood vessels to dilate, and improves blood flow.

Special Precautions

IMPORTANT SAFETY INFORMATION: SEMINTRA is for use in cats only. SEMINTRA is not for human use. Keep out of reach of children. If SEMINTRA is accidentally ingested, contact a physician. Pregnant women should avoid contact with SEMINTRA because other similar drugs have been found to harm the unborn baby during pregnancy. The most common side effects reported in field studies include vomiting, diarrhea, lethargy, dehydration, poor appetite, and weight loss. If side effects should occur, pet owners should contact their veterinarian. The safe use of SEMINTRA has not been evaluated in cats less than 9 months of age or cats that are pregnant, lactating, or intended for breeding.

Overdose Information

Immediately contact your closest emergency animal hospital or vet.

Side Effects

SEMINTRA® (telmisartan oral solution) has not been evaluated in cats with systolic blood pressure >200 mm Hg. SEMINTRA can cause mild anemia or nonregenerative anemia. Cats should be monitored for anemia when initiating treatment with SEMINTRA. SEMINTRA may cause inappetence and weight loss in some cats. Cats should be monitored for weight loss when initiating treatment with SEMINTRA. Use with caution in cats with a history of vomiting, inappetence or weight loss. The safe use of SEMINTRA in cats with hepatic disease has not been evaluated. SEMINTRA is metabolized by the liver. The safe use of SEMINTRA has not been evaluated in cats less than 9 months of age. The safe use of SEMINTRA has not been evaluated in cats that are pregnant, lactating, or intended for breeding. See Human Warnings. The safe use with other anti-hypertensive medications has not been evaluated.

Storage

Store at or below 25°C (77°F) with excursions permitted up to 40°C (104°F). Once the bottle is opened use the contents within six months.